New Section 1557 Rule: Implications and Considerations
Summary
Presented at the NAIC Spring Meeting 2024, this document discusses the implications of the new Section 1557 rule for health insurance nondiscrimination protections. It covers topics such as discriminatory benefit design, prescription drug access, and nondiscrimination on the basis of sex. The presentation also highlights key issues for regulators, including the need for enforcement and practical tips for reviewing benefit designs.
